<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Metabolomic breath analysis &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/metabolomic-breath-analysis/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 12 Jan 2026 13:47:42 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Metabolomic breath analysis &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Breath Analysis Reveals Lipid Biomarkers in Parkinson’s</title>
		<link>https://bioengineer.org/breath-analysis-reveals-lipid-biomarkers-in-parkinsons/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 12 Jan 2026 13:47:21 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Lipid biomarkers]]></category>
		<category><![CDATA[Metabolomic breath analysis]]></category>
		<category><![CDATA[neurodegenerative diseases]]></category>
		<category><![CDATA[non-invasive diagnostics]]></category>
		<category><![CDATA[Parkinson's disease diagnosis]]></category>
		<guid isPermaLink="false">https://bioengineer.org/breath-analysis-reveals-lipid-biomarkers-in-parkinsons/</guid>

					<description><![CDATA[In a groundbreaking advancement set to transform the diagnosis and understanding of Parkinson’s disease, researchers have unveiled a comprehensive metabolomic breath analysis technique that identifies lipid biomarkers linked to both genetic and idiopathic forms of the disorder. This pioneering study, published in npj Parkinson’s Disease, leverages the burgeoning field of metabolomics to explore the complex [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">316100</post-id>	</item>
	</channel>
</rss>
